Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design

Designing optimal (neo)adjuvant therapy is a crucial aspect of the treatment of non-small-cell lung carcinoma (NSCLC). Standard methods of chemotherapy, radiotherapy, and immunotherapy represent effective strategies for treatment. However, in some cases with high metastatic activity and high levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Kejík, Zdeněk, Kaplánek, Robert, Dytrych, Petr, Masařík, Michal, Veselá, Kateřina, Abramenko, Nikita, Hoskovec, David, Vašáková, Martina, Králová, Jarmila, Martásek, Pavel, Jakubek, Milan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619417/
https://www.ncbi.nlm.nih.gov/pubmed/34834295
http://dx.doi.org/10.3390/pharmaceutics13111879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619417/
https://www.ncbi.nlm.nih.gov/pubmed/34834295
http://dx.doi.org/10.3390/pharmaceutics13111879

Ejemplares similares